Scilex Holding Co. (SCLX)
2.82
-0.03
(-1.05%)
USD |
NASDAQ |
Oct 15, 16:00
2.87
+0.05
(+1.77%)
After-Hours: 20:00
Scilex Enterprise Value : 123.08M for Oct. 15, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 15, 2026 | 123.08M |
| October 14, 2026 | 123.29M |
| October 13, 2026 | 123.50M |
| October 12, 2026 | 122.94M |
| October 09, 2026 | 123.78M |
| October 08, 2026 | 124.06M |
| October 07, 2026 | 127.79M |
| October 06, 2026 | 131.10M |
| October 05, 2026 | 130.11M |
| October 02, 2026 | 131.80M |
| October 01, 2026 | 134.26M |
| September 30, 2026 | 134.54M |
| September 29, 2026 | 134.26M |
| September 28, 2026 | 134.82M |
| September 25, 2026 | 137.64M |
| September 24, 2026 | 137.99M |
| September 23, 2026 | 139.12M |
| September 22, 2026 | 140.87M |
| September 21, 2026 | 139.54M |
| September 18, 2026 | 138.69M |
| September 17, 2026 | 141.01M |
| September 16, 2026 | 139.61M |
| September 15, 2026 | 137.92M |
| September 14, 2026 | 139.12M |
| September 11, 2026 | 138.48M |
| Date | Value |
|---|---|
| September 10, 2026 | 138.76M |
| September 09, 2026 | 139.82M |
| September 08, 2026 | 141.01M |
| September 04, 2026 | 141.33M |
| September 03, 2026 | 140.38M |
| September 02, 2026 | 140.87M |
| September 01, 2026 | 141.23M |
| August 31, 2026 | 141.89M |
| August 28, 2026 | 141.44M |
| August 27, 2026 | 142.42M |
| August 26, 2026 | 142.70M |
| August 25, 2026 | 142.98M |
| August 24, 2026 | 143.05M |
| August 21, 2026 | 143.55M |
| August 20, 2026 | 144.04M |
| August 19, 2026 | 142.98M |
| August 18, 2026 | 147.84M |
| August 17, 2026 | 148.26M |
| August 14, 2026 | 150.79M |
| August 13, 2026 | 150.65M |
| August 12, 2026 | 151.78M |
| August 11, 2026 | 150.44M |
| August 10, 2026 | 150.30M |
| August 07, 2026 | 152.13M |
| August 06, 2026 | 152.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.895B |
| Corcept Therapeutics, Inc. | 11.94B |
| Veru, Inc. | 18.49M |
| Johnson & Johnson | 638.23B |
| Eli Lilly & Co. | 1.224T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -116.22M |
| Revenue (Quarterly) | 7.642M |
| Total Expenses (Quarterly) | 122.37M |
| EPS Diluted (Quarterly) | -16.65 |
| Gross Profit Margin (Quarterly) | 14.73% |
| Profit Margin (Quarterly) | -1.52K% |
| Earnings Yield | -1.77K% |
| Normalized Earnings Yield | -1183.66 |